AngioDynamics Inc
F:UG2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AngioDynamics Inc
F:UG2
|
US |
|
Morinaga & Co Ltd
OTC:MGAAF
|
JP |
Intrinsic Value
The intrinsic value of 
AngioDynamics Inc (UG2) under the Base Case is 10.52 EUR per share.
Compared with the current market price of 10.3 EUR, the stock appears
Undervalued by 2% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What AngioDynamics Does
AngioDynamics makes medical devices that doctors use in minimally invasive procedures, especially in vascular access, vascular disease, and cancer treatment. Its products include catheters, ports, ablation tools, thrombectomy devices, and other instruments that help clinicians place access lines, remove blockages, and treat tumors or abnormal tissue.
- Headquarters
- United States of America US
- Employees
- 675
- IPO date
- May 27, 2004
AngioDynamics has no economic moat
AngioDynamics Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
AngioDynamics Inc
Earnings Waterfall
AngioDynamics Inc
The intrinsic value for AngioDynamics Inc (UG2) under the Base Case is 10.52 EUR.
Compared with the current market price of 10.3 EUR, the stock appears Undervalued by 2% .
